Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients. 2020

R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

The genetic risk associated with rheumatoid arthritis (RA) includes genes regulating DNA methylation, one of the hallmarks of epigenetic re-programing, as well as many T-cell genes, with a strong MHC association, pointing to immunogenetic mechanisms as disease triggers leading to chronicity. The aim of our study was to explore DNA methylation in early, drug-naïve RA patients, towards a better understanding of early events in pathogenesis. Monocytes, naïve and memory CD4+ T-cells were sorted from 6 healthy controls and 10 RA patients. DNA methylation was assessed using a genome-wide Illumina 450K CpG promoter array. Differential methylation was confirmed using bisulfite sequencing for a specific gene promoter, ELISA for several cytokines and flow cytometry for cell surface markers. Differentially methylated (DM) CpGs were observed in 1047 genes in naïve CD4+ T-cells, 913 in memory cells and was minimal in monocytes with only 177 genes. Naive CD4+ T-cells were further investigated as presenting differential methylation in the promoter of > 500 genes associated with several disease-relevant pathways, including many cytokines and their receptors. We confirmed hypomethylation of a region of the TNF-alpha gene in early RA and differential expression of 3 cytokines (IL21, IL34 and RANKL). Using a bioinformatics package (DMRcate) and an in-house analysis based on differences in β values, we established lists of DM genes between health and RA. Publicly available gene expression data were interrogated to confirm differential expression of over 70 DM genes. The lists of DM genes were further investigated based on a functional relationship database analysis, which pointed to an IL6/JAK1/STAT3 node, related to TNF-signalling and engagement in Th17 cell differentiation amongst many pathways. Five DM genes for cell surface markers (CD4, IL6R, IL2RA/CD25, CD62L, CXCR4) were investigated towards identifying subpopulations of CD4+ T-cells undergoing these modifications and pointed to a subset of naïve T-cells, with high levels of CD4, IL2R, and CXCR4, but reduction and loss of IL6R and CD62L, respectively. Our data provided novel conceptual advances in the understanding of early RA pathogenesis, with implications for early treatment and prevention.

UI MeSH Term Description Entries
D008297 Male Males
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA

Related Publications

R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
January 2020, Frontiers in immunology,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
January 2023, Arthritis research & therapy,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
May 2017, Modern rheumatology,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
May 2015, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
March 2021, ACR open rheumatology,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
October 2022, RMD open,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
January 2019, Frontiers in immunology,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
January 2019, Annals of the rheumatic diseases,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
July 2021, Annals of the rheumatic diseases,
R Pitaksalee, and A N Burska, and S Ajaib, and J Rogers, and R Parmar, and K Mydlova, and X Xie, and A Droop, and J S Nijjar, and P Chambers, and P Emery, and R Hodgett, and I B McInnes, and F Ponchel
October 2013, International journal of rheumatic diseases,
Copied contents to your clipboard!